SCM
CGON icon

Sterling Capital Management’s CG Oncology CGON Stock Holding History

Sterling Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.9K Buy
383
+18
+5% +$1.02K ﹤0.01% 1902
2025
Q4 		$15.2K Buy
365
+230
+170% +$9.52K ﹤0.01% 2385
2025
Q3 		$5.44K Hold
135
– – ﹤0.01% 2748
2025
Q2 		$3.51K Sell
135
-270
-67% -$6.51K ﹤0.01% 2707
2025
Q1 		$9.92K Sell
405
-227
-36% -$6.39K ﹤0.01% 1863
2024
Q4 		$18.1K Buy
632
+540
+587% +$18.5K ﹤0.01% 1901
2024
Q3 		$3.47K Buy
+92
New +$3.23K ﹤0.01% 1918

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM